Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.
Monoclonal Antibodies Market Size Worth USD 572.62 Billion in 2032 | Emergen Research
Emergen Research
another link to the Monoclonal Antibodies Market Size
https://finance.yahoo.com/news/monoclonal-antibodies-market-size-worth-131700950.html
This week Company on USA tour to various Cities
take a look
https://twitter.com/EquityTrader888/status/1772554770705723893?t=UNE7aV9JeM21RLLNAjmJRA&s=19
Davey50
be pragmatic..... Monoclonal antibodies market size is over $200B
just 1% of this is worth over $2b US Dollars, which means a staggering upside for FAB......
yet you do not perceive this Knowledge or can't comprehend or process this Potential in your Brian.
let this sink in!!!!
Https://www.biospace.com/article/releases/cancer-monoclonal-antibodies-market-size-estimated-to-reach-usd-410-95-billion-by-2032/
Davy50
look at this before making silly comments.......
$200b isn't a figure I plucked out of thin air!!!
Https://www.biospace.com/article/releases/cancer-monoclonal-antibodies-market-size-estimated-to-reach-usd-410-95-billion-by-2032/
I'm surprised Company don't know this yet or Haven't Rns the Monoclonal Antibodies Market Size yet.......
Google "What is the market size for Monoclonal Antibodies"
it's over $200 billion dollar industry and rising to ¥500billion in the next few years.
only 1% of the market share is worth a look at staggering £2Billion
yes two Billion dollars.
market is missing this
News coming soon on this collaboration update......
OptiMAL® collaboration agreement
Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announces that it has signed a collaboration agreement (the "Agreement") with the National Cancer Institute ("NCI") for the use of OptiMAL® in the discovery of novel antibodies against targets selected by NCI.
Under the terms of the Agreement, Fusion will provide access to the OptiMAL® technology to NCI for deployment against an agreed number of targets, being primarily cancer targets, over a period of up to two years, in order to develop potential therapeutic antibodies against the selected targets. The parties will work together to ensure successful validation of the OptiMAL® technology and jointly publish any results from the collaboration. The validation will be run at NCI's laboratories by their staff and antibodies identified pursuant to the Agreement would be retained by NCI.
Funds managers are looking to invest in Bio Tech
https://www.thisismoney.co.uk/money/diyinvesting/article-13227289/Im-fund-manager-biotech-investor-Ailsa-Craig-thinks-rate-cuts-spark-rebound.html
Billions worth
Monoclonal Antibodies Market: The global monoclonal antibodies market size accounted for USD 201.63 billion in 2022 and is projected to hit around USD 634.64 billion by 2032, poised to grow at a CAGR of 12.2% over the forecast period from 2023 to 2032
Fusion-antibiotics-plc
just needs 1% share of the $200 Billion market share for the Monoclonal Antibodies 😳
Mcap £3m is ridiculously cheap for that sort of potential.
Mcap should go to £15m at least on the potential value
then when Contracts starts to come Sp can shoot up exponentially
Has anyone seen this
Monoclonal Antibodies Market: The global monoclonal antibodies market size accounted for USD 201.63 billion in 2022 and is projected to hit around USD 634.64 billion by 2032, poised to grow at a CAGR of 12.2% over the forecast period from 2023 to 2032
https://www.biospace.com/article/releases/cancer-monoclonal-antibodies-market-size-estimated-to-reach-usd-410-95-billion-by-2032/
Fusion Antibodies FAB just needs 1% of that $200 billion dollar market, that's is unbelievable amount of money
$200B at 1% is$2 Billion
wow!!!!
just need 1% market share and FAB would be worth billion Mcap company!
Has anyone seen this
Monoclonal Antibodies Market: The global monoclonal antibodies market size accounted for USD 201.63 billion in 2022 and is projected to hit around USD 634.64 billion by 2032, poised to grow at a CAGR of 12.2% over the forecast period from 2023 to 2032
https://www.biospace.com/article/releases/cancer-monoclonal-antibodies-market-size-estimated-to-reach-usd-410-95-billion-by-2032/
Time for Fusion Antibodies FAB to get some big contracts from the USA.
With £500billion Monoclonal Antibodies Market Size Worth, won't be hard for FAB to get £100m contract.
just matter of time
Monoclonal Antibodies Market Size Worth USD 572.62 Billion in 2032 | Emergen Research
Emergen Research
https://finance.yahoo.com/news/monoclonal-antibodies-market-size-worth-131700950.html
any wonder FAB was 60p not long ago